Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market Report by Device, Route of Administration, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The global vaccine delivery devices market size reached US$ 7.5 Billion in 2023. Looking forward, the market is projected to reach US$ 13.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.75% during 2023-2032.
Technological advancements in the systematic delivery of vaccines, such as micro-needles and electroporation, represent one of the key factors driving the market. Moreover, there is an increase in the utilization of needle-free delivery systems as they decrease needle stick injuries and the vaccine antigen dose and enhance the vaccine immunogenicity.
This, along with the rising research in the field of vaccines and the development of new vaccine delivery devices around the world, is propelling the growth of the market. In addition, governments of several countries are promoting immunization programs to prevent disabilities and deaths from vaccine-preventable diseases.
This, coupled with the growing investments by non-governmental organizations (NGOs) for various vaccination programs and campaigns globally, is positively influencing the market. Besides this, key market players are focusing on novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity.
Additionally, the expanding healthcare sector due to the increasing geriatric population and easy access to medical products and services is bolstering the market growth. Furthermore, the outbreak of coronavirus disease (COVID-19) is augmenting the sales of vaccine delivery devices worldwide.
Key Questions Answered in This Report
- What was the size of the global vaccine delivery devices market in 2023?
- What is the expected growth rate of the global vaccine delivery devices market during 2024-2032?
- What are the key factors driving the global vaccine delivery devices market?
- What has been the impact of COVID-19 on the global vaccine delivery devices market?
- What is the breakup of the global vaccine delivery devices market based on the device?
- What is the breakup of the global vaccine delivery devices market based on the route of administration?
- What is the breakup of the global vaccine delivery devices market based on end user?
- What are the key regions in the global vaccine delivery devices market?
- Who are the key players/companies in the global vaccine delivery devices market?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 138 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $7.5 Billion |
| Forecasted Market Value (USD) by 2032 | $13.5 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Competitive Landscape
- 3M Company
- Becton Dickinson and Company
- Enesi Pharma Limited
- Gerresheimer AG
- INOVIO Pharmaceuticals
- NanoPass
- Panacea Biotec Pharma Limited (Panacea Biotec)
- Pharmajet Inc.
- Schott AG (Carl-Zeiss-Stiftung)
- Terumo Corporation
- Vaxxas
Key Market Segmentation
Breakup by Device:
- Syringes
- Jet Injectors
- Others
Breakup by Route of Administration:
- Intramuscular Vaccination
- Intradermal Vaccination
- Subcutaneous Vaccination
- Others
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
For more information about this report visit https://www.researchandmarkets.com/r/i0j63p
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
